Literature DB >> 137803

The activity of four antimicrobial agents. Including three nitroimidazole compounds, against Bacteroides sp.

R Wise, J M Andrews, K A Bedford.   

Abstract

Forty strains of Bacteroides sp. were tested against three nitroimidazole compounds, metronidazole, tinidazole and nimorazole and the aminoglycosidic antibiotic spectinomycin. The effect of altering the inoculum and the presence of serum upon the minimum inhibitory concentration (MIC) was also noted. The three nitroimidazole compounds were all very active (average MIC = circa 0.25 mg/l). Tinidazole was twofold more active. The MIC of spectinomycin was 32 mg/l.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 137803     DOI: 10.1159/000221966

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  4 in total

1.  Prophylactic regimens in colorectal surgery: comparisons between metronidazole used alone or with ampicillin for one or three days.

Authors:  M Roland; T Bergan; T Bjerkeset; H Erichsen; R Hoel; S Johansen; I Liavåg; S Reinertsen; A Rosseland; T Teigan
Journal:  World J Surg       Date:  1985-08       Impact factor: 3.352

Review 2.  Tinidazole in anaerobic infections: a review of its antibacterial activity, pharmacological properties and therapeutic efficacy.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-08       Impact factor: 9.546

3.  Single dose prophylaxis with metronidazole in infants during abdominal surgery: a pharmacokinetic study.

Authors:  A Rubenson; A Rosetzsky
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

4.  Comparative evaluation of the 2-methyl-5-nitroimidazole compounds dimetridazole, metronidazole, secnidazole, ornidazole, tinidazole, carnidazole, and panidazole against Bacteroides fragilis and other bacteria of the Bacteroides fragilis group.

Authors:  L Jokipii; A M Jokipii
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.